Johnson & Johnson's COVID-19 vaccine may pose a "small possible risk" of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday.
Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine
WJZ Baltimore
The FDA announced that they will allow Emergent Biosolutions to resume production of the Johnson and Johnson covid-19 vaccine on..
